We are live on ! Find out more
LAB icon

Standard BioTools
LAB

72 hedge funds and large institutions have $138M invested in Standard BioTools in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

54% more capital invested

Capital invested by funds: $89.1M → $138M (+$48.5M)

9% more funds holding

Funds holding: 66 → 72 (+6)

1.18% more ownership

Funds ownership: 58.88% → 60.06% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

16% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 19

16% less call options, than puts

Call options by funds: $83K | Put options by funds: $99K

Holders
72
Holders Change
+6
Holders Change %
+9.09%
% of All Funds
1.14%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
16
Reduced
19
Closed
9
Calls
$83K
Puts
$99K
Net Calls
-$16K
Net Calls Change
+$17K

Top Buyers

Rank Fund Capital Flow
1
HBWM
Hollow Brook Wealth Management
New York
+$4.67M
2
Morgan Stanley
Morgan Stanley
New York
+$3.69M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$1.56M
4
PHP
Parkman Healthcare Partners
Connecticut
+$1.31M
5
EI
EAM Investors
California
+$1.24M

Top Sellers

Rank Fund Capital Flow
1
BFM
Boothbay Fund Management
New York
-$2.87M
2
CP
Caligan Partners
New York
-$2.21M
3
NIM
Needham Investment Management
New York
-$2.12M
4
HighTower Advisors
HighTower Advisors
Illinois
-$1.55M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$521K
Name Holding Trade Value Shares
Change 		Change in
Stake
SSA
26
Schonfeld Strategic Advisors
New York
$415K +$374K +143,000 New
Rockefeller Capital Management
27
Rockefeller Capital Management
New York
$382K +$1.9K +728 +0.6%
Citadel Advisors
28
Citadel Advisors
Florida
$329K +$87.6K +33,495 +42%
PCH
29
Polar Capital Holdings
United Kingdom
$290K – – –
Bank of New York Mellon
30
Bank of New York Mellon
New York
$283K -$5.39K -2,062 -2%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$279K +$65.4K +25,020 +35%
IP
32
Intellectus Partners
California
$182K – – –
JFG
33
Jefferies Financial Group
New York
$164K +$148K +56,400 New
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
$158K – – –
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$146K -$34.4K -13,144 -21%
BCPWM
36
Bradley & Co Private Wealth Management
Florida
$145K – – –
Barclays
37
Barclays
United Kingdom
$140K +$126K +48,194 New
Osaic Holdings
38
Osaic Holdings
Arizona
$138K +$53.2K +20,355 +75%
T. Rowe Price Associates
39
T. Rowe Price Associates
Maryland
$112K – – –
Jane Street
40
Jane Street
New York
$103K -$7.54K -2,883 -7%
Point72 Asset Management
41
Point72 Asset Management
Connecticut
$100K +$90.4K +34,582 New
SEI Investments
42
SEI Investments
Pennsylvania
$98K +$4.9K +1,873 +6%
JF
43
Jump Financial
Illinois
$94.1K +$84.9K +32,450 New
Charles Schwab
44
Charles Schwab
California
$90.5K – – –
Commonwealth Equity Services
45
Commonwealth Equity Services
Massachusetts
$87K – – –
EWA
46
EverSource Wealth Advisors
Alabama
$80.6K – – –
AG
47
Algert Global
California
$76K – – –
Marshall Wace
48
Marshall Wace
United Kingdom
$68.1K +$19.1K +7,300 +45%
FWA
49
Freedom Wealth Alliance
Wisconsin
$59.1K +$53.3K +20,394 New
Two Sigma Advisers
50
Two Sigma Advisers
New York
$57.7K -$26.7K -10,200 -34%
1
2
3 4

LAB Hedge Fund Activity: Q3 2023 in Review

72 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2023, worth a combined $138M — up 54% from $89.1M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new LAB positions and 9 closed out — a net gain of 6 holders — while 16 added to existing stakes and 19 trimmed.

The largest buyer was Hollow Brook Wealth Management, opening a new position worth an estimated $4.67M. The largest seller was Boothbay Fund Management, cutting an estimated $2.87M.

  • 72 institutional investors held Standard BioTools (LAB) as of Q3 2023, up from 66 in Q2 2023.
  • Funds reported $138M of Standard BioTools stock for Q3 2023, up 54% quarter-over-quarter.
  • 15 funds opened new Standard BioTools positions in Q3 2023 and 9 closed out, a net change of +6 holders.
  • The largest Standard BioTools buyer in Q3 2023 was Hollow Brook Wealth Management, an estimated $4.67M added.
  • The largest Standard BioTools seller in Q3 2023 was Boothbay Fund Management, an estimated $2.87M sold.

Based on aggregated 13F filings for Q3 2023.